These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16885777)

  • 1. HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mL.
    Mitsuya Y; Winters MA; Fessel WJ; Rhee SY; Slome S; Flamm J; Horberg M; Hurley L; Klein D; Shafer RW
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):56-9. PubMed ID: 16885777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
    Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
    JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genotypic resistance in HIV-1-infected patients with persistent low-level viremia].
    Parra-Ruiz J; Alvarez M; Chueca N; Peña A; Pasquau J; López-Ruz MA; Maroto Mdel C; Hernández-Quero J; García F
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):75-80. PubMed ID: 19254638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of genotypic resistance tests for HIV-1-infected patients with low-level virological failure.
    Elgalib A; Perry M; Aboud M; Mullen J; O'Shea S; Chrystie IL; Kulasegaram R; Tong CY
    J Clin Microbiol; 2010 Sep; 48(9):3358-9. PubMed ID: 20631106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients.
    Caby F; Valin N; Marcelin AG; Schneider L; Andrade R; Guiguet M; Tubiana R; Canestri A; Valantin MA; Peytavin G; Pacanowski J; Morand-Joubert L; Calvez V; Girard PM; Katlama C
    Scand J Infect Dis; 2010 Jul; 42(6-7):527-32. PubMed ID: 20222846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolates.
    Lafeuillade A; Poggi C; Hittinger G; Chadapaud S
    HIV Med; 2001 Oct; 2(4):231-5. PubMed ID: 11737402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.
    Prosperi MC; Mackie N; Di Giambenedetto S; Zazzi M; Camacho R; Fanti I; Torti C; Sönnerborg A; Kaiser R; Codoñer FM; Van Laethem K; Bansi L; van de Vijver DA; Geretti AM; De Luca A;
    J Antimicrob Chemother; 2011 Aug; 66(8):1886-96. PubMed ID: 21624929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.
    Masquelier B; Pereira E; Peytavin G; Descamps D; Reynes J; Verdon R; Fleury H; Garraffo R; Chêne G; Raffi F; Brun-Vézinet F;
    J Clin Virol; 2005 May; 33(1):75-8. PubMed ID: 15797369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria.
    Charpentier C; Gody JC; Tisserand P; Matta M; Fournier J; Mbitikon O; Bélec L
    Arch Virol; 2011 Sep; 156(9):1603-6. PubMed ID: 21479946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia.
    Mackie NE; Phillips AN; Kaye S; Booth C; Geretti AM
    J Infect Dis; 2010 May; 201(9):1303-7. PubMed ID: 20350161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.
    Elbeik T; Hoo BS; Campodonico ME; Dileanis J; Fay FF; Bortolozzi RL; Benetti MS; Fay OH; Marlowe N; Petrauskene O; Chernoff D; Smith L; Ng VL
    J Hum Virol; 2001; 4(6):317-28. PubMed ID: 12082398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimized protocol for detection of HIV-1 drug mutations in patients with low viral load.
    Stelzl E; Troppan KT; Winkler M; Korn K; Kessler HH
    J Virol Methods; 2010 Sep; 168(1-2):152-4. PubMed ID: 20471425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic-silica based nucleic acid extraction for Human Immunodeficiency Virus Type-1 drug-resistance testing in low viremic patients.
    Milia MG; Allice T; Gregori G; Mussino S; Orofino G; Bonora S; Ghisetti V
    J Clin Virol; 2010 Jan; 47(1):8-12. PubMed ID: 19914863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of a long-term discrepancy in drug-targeted genes in plasma HIV-1 RNA and PBMC HIV-1 DNA in the same patient.
    Usuku S; Noguchi Y; Sakamoto M; Adachi T; Sagara H; Sudo K; Nishizawa M; Kondo M; Tochikubo O; Imai M
    Jpn J Infect Dis; 2006 Apr; 59(2):122-5. PubMed ID: 16632914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic resistance of archived and circulating viral strains in the blood of treated HIV-infected individuals.
    Turriziani O; Bucci M; Stano A; Scagnolari C; Bellomi F; Fimiani C; Mezzaroma I; D'Ettorre G; Brogi A; Vullo V; Antonelli G
    J Acquir Immune Defic Syndr; 2007 Apr; 44(5):518-24. PubMed ID: 17224845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How does expert advice impact genotypic resistance testing in clinical practice?
    Badri SM; Adeyemi OM; Max BE; Zagorski BM; Barker DE
    Clin Infect Dis; 2003 Sep; 37(5):708-13. PubMed ID: 12942405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic impact of prolonged detectable HIV type 1 RNA viral load after HAART failure in a CRF01_AE-infected cohort.
    Zolfo M; Schapiro JM; Phan V; Koole O; Thai S; Vekemans M; Fransen K; Lynen L
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):727-35. PubMed ID: 20854169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
    Fofana DB; Soulié C; Baldé A; Lambert-Niclot S; Sylla M; Ait-Arkoub Z; Diallo F; Sangaré B; Cissé M; Maïga IA; Fourati S; Koita O; Calvez V; Marcelin AG; Maïga AI
    J Antimicrob Chemother; 2014 Sep; 69(9):2531-5. PubMed ID: 24855120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
    Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R;
    Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.